ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related topics

Oncology KnowledgeBASE: Daily Updates from the Evolving World of Oncology Drug Developments - ResearchAndMarkets.com

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
January 6, 2023 GMT

DUBLIN--(BUSINESS WIRE)--Jan 6, 2023--

The “Oncology KnowledgeBASE” database has been added to ResearchAndMarkets.com’s offering.

The oncology sector commands the largest share of the global pharmaceuticals market. It is a highly volatile market populated by numerous small companies and dominated by a few multinational giants.

Start-ups, based on institutional research discoveries, readily financed by eager investors, come and go as they fail, merge, or are acquired by others. Currently, Oncology KnowledgeBASE profiles over 2,000 companies actively participating in this sector and has archived another 2,200 that ceased operations over the course of 20 years.

Also, new start-ups are emerging daily nurtured in Incubators and Accelerators. There have been over 6,000 drugs that have been developed and evaluated in the last 20 years and >600 hundred have been approved for the treatment of cancer and its health-related complications.

ADVERTISEMENT

Companies profiled in the database have operations in the oncology sector, including enabling technologies, drug development/marketing of anticancer treatments, and/or in vitro assays or imaging technologies/products for the diagnosis, prognosis and management of cancer.

Additionally, the database profiles companies developing adjunct technologies/drug therapies with specific applications in the management of patients with cancer.

The Oncology KnowledgeBASE provides a comprehensive view of the status of the global oncology drug development and personalized medicine sector.

For more information about this database visit https://www.researchandmarkets.com/r/3dkf4s

View source version on businesswire.com:https://www.businesswire.com/news/home/20230106005240/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: ONCOLOGY HEALTH COMMUNICATIONS TECHNOLOGY SOFTWARE OTHER COMMUNICATIONS PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2023.

PUB: 01/06/2023 08:53 AM/DISC: 01/06/2023 08:53 AM

http://www.businesswire.com/news/home/20230106005240/en